Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 28 entries
Sorted by: Best Match Show Resources per page
Commentary: Back to the future: Failed mitral valve bioprosthesis in the setting of mitral annular calcification.

JTCVS techniques

Parchment N, Brescia AA, Ailawadi G.
PMID: 34977735
JTCVS Tech. 2021 Aug 06;10:269-270. doi: 10.1016/j.xjtc.2021.08.007. eCollection 2021 Dec.

No abstract available.

Cite
Parchment N, Brescia AA, Ailawadi G. Commentary: Back to the future: Failed mitral valve bioprosthesis in the setting of mitral annular calcification. JTCVS Tech. 2021;10:269-270doi: 10.1016/j.xjtc.2021.08.007.
Parchment, N., Brescia, A. A., & Ailawadi, G. (2021). Commentary: Back to the future: Failed mitral valve bioprosthesis in the setting of mitral annular calcification. JTCVS techniques, 10269-270. https://doi.org/10.1016/j.xjtc.2021.08.007
Parchment, Nathaniel, et al. "Commentary: Back to the future: Failed mitral valve bioprosthesis in the setting of mitral annular calcification." JTCVS techniques vol. 10 (2021): 269-270. doi: https://doi.org/10.1016/j.xjtc.2021.08.007
Parchment N, Brescia AA, Ailawadi G. Commentary: Back to the future: Failed mitral valve bioprosthesis in the setting of mitral annular calcification. JTCVS Tech. 2021 Aug 06;10:269-270. doi: 10.1016/j.xjtc.2021.08.007. eCollection 2021 Dec. PMID: 34977735; PMCID: PMC8691222.
Copy Download .nbib Format: NLM
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research

Takebe N, Naqash AR, O'Sullivan Coyne G, Kummar S, Do K, Bruns A, Juwara L, Zlott J, Rubinstein L, Piekarz R, Sharon E, Streicher H, Mittra A, Miller SB, Ji J, Wilsker D, Kinders RJ, Parchment RE, Chen L, Chang TC, Das B, Mugundu G, Doroshow JH, Chen AP.
PMID: 33863809
Clin Cancer Res. 2021 Jul 15;27(14):3834-3844. doi: 10.1158/1078-0432.CCR-21-0329. Epub 2021 Apr 16.

PURPOSE: The Wee1 kinase inhibitor adavosertib abrogates cell-cycle arrest, leading to cell death. Prior testing of twice-daily adavosertib in patients with advanced solid tumors determined the recommended phase II dose (RPh2D). Here, we report results for once-daily adavosertib.PATIENTS AND...

Cite
Takebe N, Naqash AR, O'Sullivan Coyne G, et al. Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors. Clin Cancer Res. 2021;27(14):3834-3844doi: 10.1158/1078-0432.CCR-21-0329.
Takebe, N., Naqash, A. R., O'Sullivan Coyne, G., Kummar, S., Do, K., Bruns, A., Juwara, L., Zlott, J., Rubinstein, L., Piekarz, R., Sharon, E., Streicher, H., Mittra, A., Miller, S. B., Ji, J., Wilsker, D., Kinders, R. J., Parchment, R. E., Chen, L., Chang, T. C., Das, B., Mugundu, G., Doroshow, J. H., & Chen, A. P. (2021). Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(14), 3834-3844. https://doi.org/10.1158/1078-0432.CCR-21-0329
Takebe, Naoko, et al. "Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,14 (2021): 3834-3844. doi: https://doi.org/10.1158/1078-0432.CCR-21-0329
Takebe N, Naqash AR, O'Sullivan Coyne G, Kummar S, Do K, Bruns A, Juwara L, Zlott J, Rubinstein L, Piekarz R, Sharon E, Streicher H, Mittra A, Miller SB, Ji J, Wilsker D, Kinders RJ, Parchment RE, Chen L, Chang TC, Das B, Mugundu G, Doroshow JH, Chen AP. Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors. Clin Cancer Res. 2021 Jul 15;27(14):3834-3844. doi: 10.1158/1078-0432.CCR-21-0329. Epub 2021 Apr 16. PMID: 33863809; PMCID: PMC8282703.
Copy Download .nbib Format: NLM
The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services.

AIDS care

Small LA, Huynh AK, Parchment TM.
PMID: 34839770
AIDS Care. 2022 Jan;34(1):86-94. doi: 10.1080/09540121.2021.2002253. Epub 2021 Nov 27.

Treatment among pYLHIV focuses on their physical health. However, they also experience depression and anxiety, compounded by developmental challenges and the stress of managing a chronic illness. However, limited services are available to help pYLHIV manage the emotional stressors...

Cite
Small LA, Huynh AK, Parchment TM. The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services. AIDS Care. 2021;34(1):86-94doi: 10.1080/09540121.2021.2002253.
Small, L. A., Huynh, A. K., & Parchment, T. M. (2022). The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services. AIDS care, 34(1), 86-94. https://doi.org/10.1080/09540121.2021.2002253
Small, Latoya A, et al. "The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services." AIDS care vol. 34,1 (2022): 86-94. doi: https://doi.org/10.1080/09540121.2021.2002253
Small LA, Huynh AK, Parchment TM. The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services. AIDS Care. 2022 Jan;34(1):86-94. doi: 10.1080/09540121.2021.2002253. Epub 2021 Nov 27. PMID: 34839770.
Copy Download .nbib Format: NLM
ATR inhibition reverses the resistance of homologous recombination deficient MGMT.

Oncotarget

El Touny LH, Hose C, Connelly J, Harris E, Monks A, Dull AB, Wilsker DF, Hollingshead MG, Gottholm-Ahalt M, Alcoser SY, Mullendore ME, Parchment RE, Doroshow JH, Teicher BA, Rapisarda A.
PMID: 34676045
Oncotarget. 2021 Oct 12;12(21):2114-2130. doi: 10.18632/oncotarget.28090. eCollection 2021 Oct 12.

The therapeutic efficacy of temozolomide (TMZ) is hindered by inherent and acquired resistance. Biomarkers such as MGMT expression and MMR proficiency are used as predictors of response. However, not all MGMT

Cite
El Touny LH, Hose C, Connelly J, et al. ATR inhibition reverses the resistance of homologous recombination deficient MGMT. Oncotarget. 2021;12(21):2114-2130doi: 10.18632/oncotarget.28090.
El Touny, L. H., Hose, C., Connelly, J., Harris, E., Monks, A., Dull, A. B., Wilsker, D. F., Hollingshead, M. G., Gottholm-Ahalt, M., Alcoser, S. Y., Mullendore, M. E., Parchment, R. E., Doroshow, J. H., Teicher, B. A., & Rapisarda, A. (2021). ATR inhibition reverses the resistance of homologous recombination deficient MGMT. Oncotarget, 12(21), 2114-2130. https://doi.org/10.18632/oncotarget.28090
El Touny, Lara H, et al. "ATR inhibition reverses the resistance of homologous recombination deficient MGMT." Oncotarget vol. 12,21 (2021): 2114-2130. doi: https://doi.org/10.18632/oncotarget.28090
El Touny LH, Hose C, Connelly J, Harris E, Monks A, Dull AB, Wilsker DF, Hollingshead MG, Gottholm-Ahalt M, Alcoser SY, Mullendore ME, Parchment RE, Doroshow JH, Teicher BA, Rapisarda A. ATR inhibition reverses the resistance of homologous recombination deficient MGMT. Oncotarget. 2021 Oct 12;12(21):2114-2130. doi: 10.18632/oncotarget.28090. eCollection 2021 Oct 12. PMID: 34676045; PMCID: PMC8522839.
Copy Download .nbib Format: NLM
The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services.

AIDS care

Small LA, Huynh AK, Parchment TM.
PMID: 34839770
AIDS Care. 2022 Jan;34(1):86-94. doi: 10.1080/09540121.2021.2002253. Epub 2021 Nov 27.

Treatment among pYLHIV focuses on their physical health. However, they also experience depression and anxiety, compounded by developmental challenges and the stress of managing a chronic illness. However, limited services are available to help pYLHIV manage the emotional stressors...

Cite
Small LA, Huynh AK, Parchment TM. The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services. AIDS Care. 2021;34(1):86-94doi: 10.1080/09540121.2021.2002253.
Small, L. A., Huynh, A. K., & Parchment, T. M. (2022). The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services. AIDS care, 34(1), 86-94. https://doi.org/10.1080/09540121.2021.2002253
Small, Latoya A, et al. "The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services." AIDS care vol. 34,1 (2022): 86-94. doi: https://doi.org/10.1080/09540121.2021.2002253
Small LA, Huynh AK, Parchment TM. The association between self-Esteem, stigma, and mental health among South African youth living with HIV: the need for integrated HIV care services. AIDS Care. 2022 Jan;34(1):86-94. doi: 10.1080/09540121.2021.2002253. Epub 2021 Nov 27. PMID: 34839770.
Copy Download .nbib Format: NLM
[No title available]

Cell surface (Amsterdam, Netherlands)

Upadhya R, Lam WC, Hole CR, Parchment D, Lee CK, Specht CA, Levitz SM, Lodge JK.
PMID: 34712865
Cell Surf. 2021 Oct 15;7:100066. doi: 10.1016/j.tcsw.2021.100066. eCollection 2021 Dec.

Chitosan, a deacetylated form of chitin, is required for the virulence of

Cite
Upadhya R, Lam WC, Hole CR, et al. . Cell Surf. 2021;7:100066doi: 10.1016/j.tcsw.2021.100066.
Upadhya, R., Lam, W. C., Hole, C. R., Parchment, D., Lee, C. K., Specht, C. A., Levitz, S. M., & Lodge, J. K. (2021). . Cell surface (Amsterdam, Netherlands), 7100066. https://doi.org/10.1016/j.tcsw.2021.100066
Upadhya, Rajendra, et al. "." Cell surface (Amsterdam, Netherlands) vol. 7 (2021): 100066. doi: https://doi.org/10.1016/j.tcsw.2021.100066
Upadhya R, Lam WC, Hole CR, Parchment D, Lee CK, Specht CA, Levitz SM, Lodge JK. . Cell Surf. 2021 Oct 15;7:100066. doi: 10.1016/j.tcsw.2021.100066. eCollection 2021 Dec. PMID: 34712865; PMCID: PMC8529172.
Copy Download .nbib Format: NLM
Familial and Contextual Influences on Children's Prosocial Behavior: South African Caregivers as Adult Protective Shields in Enhancing Child Mental Health.

Global social welfare : research, policy & practice

Parchment TM, Small L, Osuji H, McKay M, Bhana A.
PMID: 28401033
Glob Soc Welf. 2016 Mar;3(1):1-10. doi: 10.1007/s40609-016-0042-8. Epub 2016 Feb 04.

BACKGROUND: The mental health of children is too frequently overlooked in resource scarce low and middle-income countries. South Africa represents one of many country contexts struggling to meet the mental health needs of large numbers of young people. Family...

Cite
Parchment TM, Small L, Osuji H, et al. Familial and Contextual Influences on Children's Prosocial Behavior: South African Caregivers as Adult Protective Shields in Enhancing Child Mental Health. Glob Soc Welf. 2016;3(1):1-10doi: 10.1007/s40609-016-0042-8.
Parchment, T. M., Small, L., Osuji, H., McKay, M., & Bhana, A. (2016). Familial and Contextual Influences on Children's Prosocial Behavior: South African Caregivers as Adult Protective Shields in Enhancing Child Mental Health. Global social welfare : research, policy & practice, 3(1), 1-10. https://doi.org/10.1007/s40609-016-0042-8
Parchment, Tyrone M, et al. "Familial and Contextual Influences on Children's Prosocial Behavior: South African Caregivers as Adult Protective Shields in Enhancing Child Mental Health." Global social welfare : research, policy & practice vol. 3,1 (2016): 1-10. doi: https://doi.org/10.1007/s40609-016-0042-8
Parchment TM, Small L, Osuji H, McKay M, Bhana A. Familial and Contextual Influences on Children's Prosocial Behavior: South African Caregivers as Adult Protective Shields in Enhancing Child Mental Health. Glob Soc Welf. 2016 Mar;3(1):1-10. doi: 10.1007/s40609-016-0042-8. Epub 2016 Feb 04. PMID: 28401033; PMCID: PMC5385243.
Copy Download .nbib Format: NLM
Topoisomerase I inhibitors and drug resistance.

Cytotechnology

Parchment RE, Pessina A.
PMID: 19002789
Cytotechnology. 1998 Sep;27(1):149-64. doi: 10.1023/A:1008008719699.

DNA topoisomerase I is a nuclear enzyme which catalyzes the conversion of the DNA topology by introducing single-strand breaks into the DNA molecule. This enzyme represents a novel and distinct molecule target for cancer therapy by antitopoisomerase drugs belonging...

Cite
Parchment RE, Pessina A. Topoisomerase I inhibitors and drug resistance. Cytotechnology. 1998;27(1):149-64doi: 10.1023/A:1008008719699.
Parchment, R. E., & Pessina, A. (1998). Topoisomerase I inhibitors and drug resistance. Cytotechnology, 27(1), 149-64. https://doi.org/10.1023/A:1008008719699
Parchment, R E, and Pessina, A. "Topoisomerase I inhibitors and drug resistance." Cytotechnology vol. 27,1 (1998): 149-64. doi: https://doi.org/10.1023/A:1008008719699
Parchment RE, Pessina A. Topoisomerase I inhibitors and drug resistance. Cytotechnology. 1998 Sep;27(1):149-64. doi: 10.1023/A:1008008719699. PMID: 19002789; PMCID: PMC3449562.
Copy Download .nbib Format: NLM
[No title available]

Cell surface (Amsterdam, Netherlands)

Upadhya R, Lam WC, Hole CR, Parchment D, Lee CK, Specht CA, Levitz SM, Lodge JK.
PMID: 34712865
Cell Surf. 2021 Oct 15;7:100066. doi: 10.1016/j.tcsw.2021.100066. eCollection 2021 Dec.

Chitosan, a deacetylated form of chitin, is required for the virulence of

Cite
Upadhya R, Lam WC, Hole CR, et al. . Cell Surf. 2021;7:100066doi: 10.1016/j.tcsw.2021.100066.
Upadhya, R., Lam, W. C., Hole, C. R., Parchment, D., Lee, C. K., Specht, C. A., Levitz, S. M., & Lodge, J. K. (2021). . Cell surface (Amsterdam, Netherlands), 7100066. https://doi.org/10.1016/j.tcsw.2021.100066
Upadhya, Rajendra, et al. "." Cell surface (Amsterdam, Netherlands) vol. 7 (2021): 100066. doi: https://doi.org/10.1016/j.tcsw.2021.100066
Upadhya R, Lam WC, Hole CR, Parchment D, Lee CK, Specht CA, Levitz SM, Lodge JK. . Cell Surf. 2021 Oct 15;7:100066. doi: 10.1016/j.tcsw.2021.100066. eCollection 2021 Dec. PMID: 34712865; PMCID: PMC8529172.
Copy Download .nbib Format: NLM
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.

Investigational new drugs

Kummar S, Srivastava AK, Navas T, Cecchi F, Lee YH, Bottaro DP, Park SR, Do KT, Jeong W, Johnson BC, Voth AR, Rubinstein L, Wright JJ, Parchment RE, Doroshow JH, Chen AP.
PMID: 34180036
Invest New Drugs. 2021 Dec;39(6):1577-1586. doi: 10.1007/s10637-021-01138-x. Epub 2021 Jun 28.

The vascular endothelial growth factor (VEGF)/VEGFR and hepatocyte growth factor (HGF)/c-MET signaling pathways act synergistically to promote angiogenesis. Studies indicate VEGF inhibition leads to increased levels of phosphorylated c-MET, bypassing VEGF-mediated angiogenesis and leading to chemoresistance. We conducted a...

Cite
Kummar S, Srivastava AK, Navas T, et al. Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors. Invest New Drugs. 2021;39(6):1577-1586doi: 10.1007/s10637-021-01138-x.
Kummar, S., Srivastava, A. K., Navas, T., Cecchi, F., Lee, Y. H., Bottaro, D. P., Park, S. R., Do, K. T., Jeong, W., Johnson, B. C., Voth, A. R., Rubinstein, L., Wright, J. J., Parchment, R. E., Doroshow, J. H., & Chen, A. P. (2021). Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors. Investigational new drugs, 39(6), 1577-1586. https://doi.org/10.1007/s10637-021-01138-x
Kummar, Shivaani, et al. "Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors." Investigational new drugs vol. 39,6 (2021): 1577-1586. doi: https://doi.org/10.1007/s10637-021-01138-x
Kummar S, Srivastava AK, Navas T, Cecchi F, Lee YH, Bottaro DP, Park SR, Do KT, Jeong W, Johnson BC, Voth AR, Rubinstein L, Wright JJ, Parchment RE, Doroshow JH, Chen AP. Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors. Invest New Drugs. 2021 Dec;39(6):1577-1586. doi: 10.1007/s10637-021-01138-x. Epub 2021 Jun 28. PMID: 34180036; PMCID: PMC8541958.
Copy Download .nbib Format: NLM
Perceived Benefits of a Multiple Family Group for Children with Behavior Problems and their Families.

Social work with groups

Acri MC, Hamovitch EK, Lambert K, Galler M, Parchment TM, Bornheimer LA.
PMID: 31827309
Soc Work Groups. 2019;42(3):197-212. doi: 10.1080/01609513.2019.1567437. Epub 2019 Feb 04.

Multiple family groups (MFG) have shown to have promising results for children with behavioral difficulties. The 4Rs and 2Ss is a curriculum-based multiple family group model for families of children with disruptive behavior disorders, who live in poverty-impacted communities....

Cite
Acri MC, Hamovitch EK, Lambert K, et al. Perceived Benefits of a Multiple Family Group for Children with Behavior Problems and their Families. Soc Work Groups. 2019;42(3):197-212doi: 10.1080/01609513.2019.1567437.
Acri, M. C., Hamovitch, E. K., Lambert, K., Galler, M., Parchment, T. M., & Bornheimer, L. A. (2019). Perceived Benefits of a Multiple Family Group for Children with Behavior Problems and their Families. Social work with groups, 42(3), 197-212. https://doi.org/10.1080/01609513.2019.1567437
Acri, Mary C, et al. "Perceived Benefits of a Multiple Family Group for Children with Behavior Problems and their Families." Social work with groups vol. 42,3 (2019): 197-212. doi: https://doi.org/10.1080/01609513.2019.1567437
Acri MC, Hamovitch EK, Lambert K, Galler M, Parchment TM, Bornheimer LA. Perceived Benefits of a Multiple Family Group for Children with Behavior Problems and their Families. Soc Work Groups. 2019;42(3):197-212. doi: 10.1080/01609513.2019.1567437. Epub 2019 Feb 04. PMID: 31827309; PMCID: PMC6905507.
Copy Download .nbib Format: NLM
Beyond Ti.

ACS nano

Han M, Shuck CE, Rakhmanov R, Parchment D, Anasori B, Koo CM, Friedman G, Gogotsi Y.
PMID: 32163265
ACS Nano. 2020 Apr 28;14(4):5008-5016. doi: 10.1021/acsnano.0c01312. Epub 2020 Mar 17.

New ultrathin and multifunctional electromagnetic interference (EMI) shielding materials are required for protecting electronics against electromagnetic pollution in the fifth-generation networks and Internet of Things era. Micrometer-thin Ti

Cite
Han M, Shuck CE, Rakhmanov R, et al. Beyond Ti. ACS Nano. 2020;14(4):5008-5016doi: 10.1021/acsnano.0c01312.
Han, M., Shuck, C. E., Rakhmanov, R., Parchment, D., Anasori, B., Koo, C. M., Friedman, G., & Gogotsi, Y. (2020). Beyond Ti. ACS nano, 14(4), 5008-5016. https://doi.org/10.1021/acsnano.0c01312
Han, Meikang, et al. "Beyond Ti." ACS nano vol. 14,4 (2020): 5008-5016. doi: https://doi.org/10.1021/acsnano.0c01312
Han M, Shuck CE, Rakhmanov R, Parchment D, Anasori B, Koo CM, Friedman G, Gogotsi Y. Beyond Ti. ACS Nano. 2020 Apr 28;14(4):5008-5016. doi: 10.1021/acsnano.0c01312. Epub 2020 Mar 17. PMID: 32163265.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 28 entries